Earnings call transcripts

Management framed the year around execution and a larger self-funded investment plan, while arguing Montana rate lag remains the main constraint on growth consistency.

Management framed 2025 as a data year, highlighting faster enrollment, a longer treatment extension, and a differentiated safety thesis for peripheral CB1 inhibition.

Management framed 2024 as a difficult EV-market year, prioritizing cost reductions and profitability while arguing Wallbox can capture eventual demand recovery.

Management framed Q3 as a temporary setback from weak European demand and inventory charges, while prioritizing profitability over growth assumptions.

Management framed the quarter as execution amid a slower-than-expected EV market, emphasizing margin gains, cost control, strategic partnerships and the path to profitability.

Management framed Q1 as an execution and margin-turnaround quarter, while attributing softer-than-expected results mainly to order timing and market softness.

Management framed 2024 as a conversion and execution year, emphasizing InnovizTwo readiness, cost discipline, and customer decisions delayed rather than lost.

Management framed 2023 as a year of channel disruption and cost restructuring, positioning partnerships, DC growth and lower spending as the basis for 2024 profitability.

Management framed the call around rapid GLP-1-led growth, expanding capacity and evidence beyond weight loss, while stressing supply constraints and disciplined rollout.

Management framed Q3 as evidence that a leaner, more disciplined Shopify can sustain growth while expanding its unified commerce proposition.

Management framed the quarter as a painful channel correction but emphasized cost cuts, DC growth and ABL as the route to 2024 profitability.

Management framed recovery as slower than expected, prioritizing credit quality, cost control and a shift toward guarantees and consumer finance.